<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02317068</url>
  </required_header>
  <id_info>
    <org_study_id>UMSU-Cardiology-4</org_study_id>
    <nct_id>NCT02317068</nct_id>
  </id_info>
  <brief_title>Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Urmia University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Urmia University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine whether increasing atrial base rate pacing to achieve at least
      75-80% atrial pacing in patients with sick sinus syndrome undergoing the implementation of
      dual-chamber pacemaker can be useful to prevent or decrease the atrial fibrillation during 6
      months follow-up duration.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial high rate/Automatic mode switch episodes</measure>
    <time_frame>During 6 Months</time_frame>
    <description>The number of AHR/AMS episodes recorded by pacemaker</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>During 6 months</time_frame>
    <description>The development of stroke during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>During 6 months</time_frame>
    <description>The development of MI during follow-up confirmed by ischemic chest pain, 12-ECG, or cardiac enzyme elevation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure</measure>
    <time_frame>During 6 months</time_frame>
    <description>The development or progression of heart failure during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worsening Functional Class</measure>
    <time_frame>During 6 months</time_frame>
    <description>The worsening of functional class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>During 6 months</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Sick Sinus Syndrome</condition>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>High Atrial Base Rate Pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The base rate of pacemaker will be determined 75-100 beats/minute in condition that during first step of follow-up, his/her atrial pacing will be more than 80% of atrial high rate/automatic mode switch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Device Default</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The base rate of pacemaker will be determined 60 beats/minute</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HBR</intervention_name>
    <arm_group_label>High Atrial Base Rate Pacing</arm_group_label>
    <other_name>High Atrial Base Rate Pacing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DD</intervention_name>
    <arm_group_label>Device Default</arm_group_label>
    <other_name>Device Default</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sick sinus syndrome patients having dual-chamber pacemaker

          -  Having paroxysmal AF defined as at least 2 episodes of AHR/AMS &gt;190 b/min lasting &gt;6
             minutes

          -  Having normal atrioventricular conduction

        Exclusion Criteria:

          -  Other clinical indications for pacing except sick sinus syndrome
             (bradycardia-tachycardia syndrome)

          -  History of acute coronary syndrome

          -  Significant heart valve disease

          -  Chronic AF before randomization

          -  Overt heart failure

          -  Malignancy

          -  Any reasons for antiarrhythmic medication use

          -  Inability to follow patients every 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seyyed-al-Shohada Heart Center, UMSU</name>
      <address>
        <city>Urmia</city>
        <state>West-Azerbaijan</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2014</study_first_submitted>
  <study_first_submitted_qc>December 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2014</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Urmia University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Chancellor of research</investigator_full_name>
    <investigator_title>Vice-Chancellor for Research in UMSU</investigator_title>
  </responsible_party>
  <keyword>sick sinus syndrome</keyword>
  <keyword>paroxysmal atrial fibrillation</keyword>
  <keyword>atrial pacing</keyword>
  <keyword>high atrial base rate pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

